Archive for the ‘Diagnostic Medicine’ Category

“Super Aspirin”

Friday, June 18th, 2010
Nearly a thing of the past

Nearly a thing of the past

“Super Asprin” makes it’s mark.

John Gilmer has broken through the aspirin barrier to form this “Super Asprin”. He is now apparently in talks with Solvatrin Theraputics regarding developing the drug.

Solvatrin Theraputics are the company behind what has now been named as “Super Aspirin”, and are in talks with a number of multinational pharma companies.

Based in Cork, the company expects the super product to be “on the shelf” in the next two years. Regulatory approval pending, the sale are set to top €500m in the space of 8 years!

Dr John Gilmer has spent in excess of 10 years working on the “Super Aspirin” believes it will give you all the benefits of aspirin but not the gastro-intestinal bleeding side effect. In order to protect the intestine and stomach lining, Gilmer discovered that he could deactivate the aspirin and re-activate at a later stage by enzymes naturally present in the blood. Basically, the aspirin content content becomes active as soon as it reaches the bloodstream.

“Our research has shown the market demands a solution to the side effects of aspirin and our drug directly addresses this problem” says c0-founder Pat O’Flynn.

It appears that June is a good month for Research, Development and Pharmaceuticals – Gilmer’s 10 years hard work has finally paid off

Chief Science Officer

Wednesday, May 5th, 2010

Pharmacy Science

Pharmacy Science

Chief Scientific (Pharmacy) Officer – Limerick

 

We are currently looking for a fully qualified Pharmacist for a Chief Scientific Officer role in Limerick.

This is a start up client.

This Science Officer must be a qualified Pharmacist

The ideal candidate will have a minimum of five years experience and at least two years must be spent working as a Hospital Pharmacist.

This person must have extensive experience in working with the HSE or the NHS. 

Science Officers would have to reside in Limerick or be willing to relocate to Limerick – this is a Must 

This is a permanent Science Officer role for Pharmacists

If you are interested in this job please contact Elaine on 01-2016363 or goto 

 http://www.jackiebrownmedical.ie/jobs_ireland.php?url=jobs

Elan $900m Sale

Wednesday, April 28th, 2010
Eland to sell off EDT

Eland to sell off EDT

 

Plans to sell Elan’s drug technology business EDT may rise a portion from when Kelly Martin aimed to sell in 2008.

 

Elan’s EDT is said to be worth $900m should it float on the US Stock market. Elan almost sold off for $1.4bn in 2008 with a number of equities reaching the second round of bidding.

Between the collapse of Lehman Brothers and financial panic, the deal was scuppered.
Here’s hoping the deal goes their way this time around!

Lilly to take on Pfizer Animal Health

Thursday, April 22nd, 2010

 

Lilly aquisition of Pfizer Animal Health

Lilly aquisition of Pfizer Animal Health

A deal has been agreed between Pfizer Animal Health and Lilly which sees a transfer of a number of Pfizer’s assets to Lilly.

The agreement includes the acquisition of one of their Sligo Manufacturing Plants. All staff will be offered positions with Lilly.

European rights to many vaccines, parasiticides and feed additives are being sold off to Elanco, Lilly’s animal health division as part and parcel of its recent procurement of competitor Wyeth.

With the closing of this deal still to be approved, Pfizer are said to be receiving an undisclosed payment upfront.

President of Elanco, Jeff Simmons has welcomed the procurement, saying that Pfizer’s portfolio and plant is “a natural fit for Elanco and positions us well for sustained growth”

“Through this acquisition, we will expand and diversify our European presence with new market-leading products, augment our growing portfolio of companion animal medicines, and acquire new biologic and vaccine capabilities. We are excited about these new opportunities to improve animal health and protein production, and deliver greater value to our customers”

Crospon hits America

Wednesday, April 14th, 2010
Gastric -Band Technology

Gastric -Band Technology

Following FDA approval for their EndoFLIP product, Medical Device developer Crospon has broken into the US market.

Crospon develops medical devices within the area of gastroenterology specifically in monitoring, diagnosis and therapy.

The World Congress of Endoscopic Surgery were presented with pilot clinical trial results for the optimum stoma size for gastric band adjustment.

Following the release in the European market in 2009, EndoFLIP will now be launched in the US market.

“Gastric banding is the fastes-growing class of bariatric surgery in the US, and we believe that EndoFLIP can bring a new science to gastric-band adjustment”, says Larry Fulton, VP Sales for the Americas.

Crospon Principal investigator Dr Robert G Snow also added, “In addition, we look forward to collaborating with a number of new leading bariatric surgery study centres inside and outside of the US as we collectively seek to better define new techniques for best use of the EndoFLIP system for gastric band adjustments”.

Killing Leukaemeia

Monday, November 2nd, 2009
3- 5 years from Killing Cancer

3- 5 years from Killing Cancer

Killing Leukaemia has been the objective of  Cancer Research Scientists for decades. Today that objective has come a step closer with the announcement in the international journal, Cancer Research , that TCD in partnership with the University of Sienna have discovered a new drug called PBOX-15 capable of killing cancerous cells in adult patients with poor prognosis.

R&D is still at an early stage however with development of a viable drug between 3- 5 years from being produced according to Professor Mark Lawlor of TCD’S school of medicine. The study itself involved research across the disciplines of molecular, chemistry and biochemistry at TCD together with contributions from Research colleagues in Belfast City Hospital, Siennna and St James Hospital Dublin.

MRI-Magnetic Resonance Imaging

Thursday, October 1st, 2009
MRI Imaging Technology

MRI Imaging Technology

Good morning again and welcome to My science jobs and an introduction to MRI -Magnetic Resonance Imaging.

Recently a friend of mine undertook an MRI scan, which for some people can be an intimidating and daunting experience.

My friend’s experience with her Radiologist however was both pleasant and reassuring as she was guided through the process with understanding and confidence. In less than fifteen minutes (the typical duration) the procedure was over, and she was able to take away a CD of  the full scan imaging procedure providing detailed diagnostic information that her doctor’s predecessors could only have dreamt of scarcely thirty years earlier.  Some knowledge on the subject  then may be enlightening to those about to undertake an MRI now or in the future.

What is an MRI? An MRI (Magnetic Resonance Imaging) is a  technique used in radiology to  provide enhanced understanding and visualisation of the internal structure and function of a patients body. It has far greater contrast to CT (Computer Tomography) making it especially useful for imaging Oncological conditions. It does not use  ionising radiation but instead utilises an extremely powerful magnetic field to align the nuclear magnetisation of hydrogen atoms found in water within the Human body.

Radio Frequency waves are then used to systematically alter the alignment of the magnetisation  fields, causing the hydrogen atoms to produce a rotating or resonating magnetic field which is detectable by the scanner. This signal can be controlled in turn by other magnetic fields allowing an image to be built of specific and precise parts of the patient’s body.

The technology is as recent as 1973 when the first image was produced, the first human images being later published in 1977.  Originally termed as NMRI (Nuclear Magenetic Resonance Imaging) it is now termed MRI due to poor public receptiveness to the term Nuclear as  being allied to percieved possible harmful effects of exposure to  Nuclear Ionising Radiation and therefore being a discouragment to patients.

Those interested in pursuing  medical job opportunities for radiological medical professionals  in Ireland may wish to consider Irish recruitment agencies such as Jackie Brown Medical. This particular specialist medical recruitment agency also sources medical jobs for sonographers who work in the field of sonography or ultrasound and have found themselves in great demand from clients seeking both radiologists and sonographers.

Tomorrow we look at ultrasound technology and its applications in the field of medical scientific research

MyScienceJobs- Imaging Technology

Wednesday, September 30th, 2009
Sonographer carrying out an Ultrasound

Sonographer carrying out an Ultrasound

Welcome to Mysciencejobs where today we are looking at imaging technology as applied to the fields of medical science . In particular we will look at Radiology and ultrasonics, both similar but distinct branches of diagnostic medicine undertaken specifically by Radiologists and Sonographers.

Radiologists direct an array of imaging technologies such as (CT) computed tomography, (PET) Positron Emission Tomograph, Nuclear Medicine and (MRI) Magnetic Resonance Imaging. Radiology is amongst the most competitive branches of medicine with further advances in computer technology leading to rapid expansion in the field.

Sonographers are another specialist branch of  diagnostic medical professionals who utilse ultrasound to diagnose various medical conditions though the use of ultrasonics by producing imaging via scans, 3D, and Video. Sonographers require an indepth understanding of ultrasound physics, cross sectional anatomy, physiology, pathology and communication skills.

Career opportunities for medical professionals in these fields have grown considerably in Ireland despite current economic conditions and as a result Irish recruitment agencies such as Jackie Brown Medical have found themselves in great demand from clients seeking both radiologists and sonographers.